Breaking News Instant updates and real-time market news.

SUPN

Supernus

$24.69

0.91 (3.83%)

07:40
10/11/16
10/11
07:40
10/11/16
07:40

Supernus Pharma trading halted, news pending

  • 11

    Oct

SUPN Supernus
$24.69

0.91 (3.83%)

08/04/16
JEFF
08/04/16
NO CHANGE
Target $28
JEFF
Buy
Supernus price target raised to $28 from $23 at Jefferies
Jefferies analyst David Steinberg raised his price target for Supernus Pharmaceuticals to $28 saying the company reported "solid" Q2 results. The analyst sees increased odds of a potential near-term settlement on Oxtellar and Trokendi now that Teva's (TEVA) acquisition of Allergan's (AGN) generics business has closed. Steinberg keeps a Buy rating on Supernus.
07/18/16
NORL
07/18/16
DOWNGRADE
NORL
Market Perform
Supernus downgraded to Market Perform from Outperform at Northland
07/18/16
PIPR
07/18/16
DOWNGRADE
Target $23
PIPR
Neutral
Supernus downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst David Amsellem downgraded Supernus Pharmaceuticals to Neutral citing valuation with the shares up 63% year-to-date. The analyst keeps a $23 price target for the shares.
06/13/16
RHCO
06/13/16
NO CHANGE
RHCO
Large pharma companies should be bought on weakness, says SunTrust
SunTrust says it expects large pharma companies to outperform this year, driven by new products, accelerating long-term growth rates, attractive dividend yields, and under ownership. It says that Bristol-Myers (BMY) and Eli Lilly (LLY) are its favorite names in growth, while AbbVie (ABBV) is its favorite value stock. It calls Shire (SHPG) its top pick and Supernus (SUPN) its "catch-up trade in specialized pharma."

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.